Tumor growth inhibitory effect of ADAMTS1 is accompanied by the inhibition of tumor angiogenesis

Cancer Science

Volumn 103, Issue 10, 2012, Pages 1889-1897

  Obika, Masanari ^a   Ogawa, Hiroko ^a   Takahashi, Katsuyuki ^a   Li, Jiayi ^a   Hatipoglu, Omer Faruk ^a   Cilek, Mehmet Zeynel ^a   Miyoshi, Toru ^a   Inagaki, Junko ^a   Ohtsuki, Takashi ^a   Kusachi, Shozo ^b   Ninomiya, Yoshifumi ^a   Hirohata, Satoshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMTS1 PROTEIN; CASPASE 3; LIPOCORTIN 5;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CATALYTIC DOMAIN DELETED A DISINTEGRIN AND METALLOPROTEINASE WITH THROMBOSPONDIN MOTIFS1 GENE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECOMBINANT GENE;

ADAM PROTEINS; ANIMALS; BLOTTING, WESTERN; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; RATS; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84867233885     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2012.02381.x     Document Type: Article

References (39)

1. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407: 249-57.
2. Benouchan M, Colombo BM. Anti-angiogenic strategies for cancer therapy (Review). Int J Oncol 2005; 27: 563-71.
3. Folkman J. Angiogenesis. Annu Rev Med 2006; 57: 1-18.
4. O'Reilly MS, Holmgren L, Chen C, Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 1996; 2: 689-92.
5. Miyoshi T, Hirohata S, Ogawa H et al. Tumor-specific expression of the RGD-alpha3(IV)NC1 domain suppresses endothelial tube formation and tumor growth in mice. FASEB J 2006; 20: 1904-6.
6. Apte SS. A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motifs: the ADAMTS family. Int J Biochem Cell Biol 2004; 36: 981-5.
7. Fernandes RJ, Hirohata S, Engle JM et al. Procollagen II amino propeptide processing by ADAMTS-3. Insights on dermatosparaxis. J Biol Chem 2001; 276: 31502-9.
8. Dong JF, Moake JL, Nolasco L et al. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood 2002; 100: 4033-9.
9. Lammle B, Kremer Hovinga JA, Alberio L. Thrombotic thrombocytopenic purpura. J Thromb Haemost 2005; 3: 1663-75.
10. Tortorella MD, Burn TC, Pratta MA et al. Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science 1999; 284: 1664-6.
11. Kuno K, Okada Y, Kawashima H et al. ADAMTS-1 cleaves a cartilage proteoglycan, aggrecan. FEBS Lett 2000; 478: 241-5.
12. Russell DL, Doyle KM, Ochsner SA, Sandy JD, Richards JS. Processing and localization of ADAMTS-1 and proteolytic cleavage of versican during cumulus matrix expansion and ovulation. J Biol Chem 2003; 278: 42330-9.
13. Lee NV, Sato M, Annis DS et al. ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2. EMBO J 2006; 25: 5270-83.
14. Sandy JD, Westling J, Kenagy RD et al. Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4. J Biol Chem 2001; 276: 13372-8.
15. Vazquez F, Hastings G, Ortega MA et al. METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity. J Biol Chem 1999; 274: 23349-57.
16. Kuno K, Bannai K, Hakozaki M, Matsushima K, Hirose K. The carboxyl-terminal half region of ADAMTS-1 suppresses both tumorigenicity and experimental tumor metastatic potential. Biochem Biophys Res Commun 2004; 319: 1327-33.
17. Rocks N, Paulissen G, Quesada-Calvo F et al. ADAMTS-1 metalloproteinase promotes tumor development through the induction of a stromal reaction in vivo. Cancer Res 2008; 68: 9541-50.
18. Casal C, Torres-Collado AX, Plaza-Calonge Mdel C et al. ADAMTS1 contributes to the acquisition of an endothelial-like phenotype in plastic tumor cells. Cancer Res 2010; 70: 4676-86.
19. Reynolds LE, Watson AR, Baker M et al. Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndrome. Nature 2010; 465: 813-7.
20. Pedchenko V, Zent R, Hudson BG. Alpha(v)beta3 and alpha(v)beta5 integrins bind both the proximal RGD site and non-RGD motifs within noncollagenous (NC1) domain of the alpha3 chain of type IV collagen: implication for the mechanism of endothelia cell adhesion. J Biol Chem 2004; 279: 2772-80.
21. Hirohata S, Wang LW, Miyagi M et al. Punctin, a novel ADAMTS-like molecule, ADAMTSL-1, in extracellular matrix. J Biol Chem 2002; 277: 12182-9.
22. Nakamura K, Hirohata S, Murakami T et al. Dynamic Induction of ADAMTS1 Gene in the Early Phase of Acute Myocardial Infarction. J Biochem (Tokyo) 2004; 136: 439-46.
23. Demircan K, Hirohata S, Nishida K et al. ADAMTS-9 is synergistically induced by interleukin-1beta and tumor necrosis factor alpha in OUMS-27 chondrosarcoma cells and in human chondrocytes. Arthritis Rheum 2005; 52: 1451-60.
24. Cilek MZ, Hirohata S, Faruk Hatipoglu O et al. AHR, a novel acute hypoxia-response sequence, drives reporter gene expression under hypoxia in vitro and in vivo. Cell Biol Int 2011; 35: 1-8.
25. Sezaki S, Hirohata S, Iwabu A et al. Thrombospondin-1 is induced in rat myocardial infarction and its induction is accelerated by ischemia/reperfusion. Exp Biol Med (Maywood) 2005; 230: 621-30.
26. Hatipoglu OF, Hirohata S, Cilek MZ et al. ADAMTS1 is a unique hypoxic early response gene expressed by endothelial cells. J Biol Chem 2009; 284: 16325-33.
27. Cory AH, Owen TC, Barltrop JA, Cory JG. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun 1991; 3: 207-12.
28. Nagata D, Mogi M, Walsh K. AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress. J Biol Chem 2003; 278: 31000-6.
29. Ito H, Kanzawa T, Miyoshi T et al. Therapeutic efficacy of PUMA for malignant glioma cells regardless of p53 status. Hum Gene Ther 2005; 16: 685-98.
30. Furumatsu T, Yamaguchi N, Nishida K et al. Endostatin inhibits adhesion of endothelial cells to collagen I via alpha(2)beta(1) integrin, a possible cause of prevention of chondrosarcoma growth. J Biochem 2002; 131: 619-26.
31. Toeda K, Nakamura K, Hirohata S et al. Versican is induced in infiltrating monocytes in myocardial infarction. Mol Cell Biochem 2005; 280: 47-56.
32. Yonezawa T, Hattori S, Inagaki J et al. Type IV collagen induces expression of thrombospondin-1 that is mediated by integrin alpha1beta1 in astrocytes. Glia 2010; 58: 755-67.
33. Rodriguez-Manzaneque JC, Milchanowski AB, Dufour EK, Leduc R, Iruela-Arispe ML. Characterization of METH-1/ADAMTS1 processing reveals two distinct active forms. J Biol Chem 2000; 275: 33471-9.
34. Iruela-Arispe ML, Carpizo D, Luque A. ADAMTS1: a matrix metalloprotease with angioinhibitory properties. Ann N Y Acad Sci 2003; 995: 183-90.
35. Fu Y, Nagy JA, Brown LF et al. Proteolytic cleavage of versican and involvement of ADAMTS-1 in VEGF-A/VPF-induced pathological angiogenesis. J Histochem Cytochem 2011; 59: 463-73.
36. Brown HM, Dunning KR, Robker RL, Pritchard M, Russell DL. Requirement for ADAMTS-1 in extracellular matrix remodeling during ovarian folliculogenesis and lymphangiogenesis. Dev Biol 2006; 300: 699-709.
37. Luque A, Carpizo DR, Iruela-Arispe ML. ADAMTS1/METH1 inhibits endothelial cell proliferation by direct binding and sequestration of VEGF165. J Biol Chem 2003; 278: 23656-65.
38. Jimenez B, Volpert OV, Crawford SE, Febbraio M, Silverstein RL, Bouck N. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med 2000; 6: 41-8.
39. Ren B, Yee KO, Lawler J, Khosravi-Far R. Regulation of tumor angiogenesis by thrombospondin-1. Biochim Biophys Acta 2006; 1765: 178-88.